Artelo Biosciences reprices options to $1.55, resets vesting over 3 years for retention

ARTELO BIOSCIENCES, INC.

Compensation Committee amends options with exercise price ≥$1.99 to new price of $1.55 (Feb 28 closing).
New vesting: 1/3 vests on first anniversary, then 1/36 monthly; all previously unvested shares reset.
CEO Greg Gorgas holds 274,308 option shares with original range $3.15-$39.90 affected.
Change applies to employees and non-employee directors; no new dilution from additional grants.
Company aims to retain key contributors while preserving cash resources.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.